• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biostem Technologies Inc (OP:BSEM)

15.20 +0.08 (+0.55%)
Streaming Delayed Price Updated: 3:58 PM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 84,656
Open 15.25
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 15.11
Today's Range 14.95 - 15.45
52wk Range 6.770 - 28.26
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)
July 16, 2024
Via AB Newswire
Exposures Product Safety
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)
July 15, 2024
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property Product Safety

Performance

YTD
+6.9%
+6.9%
1 Month
+17.9%
+17.9%
3 Month
-11.3%
-11.3%
6 Month
-38.5%
-38.5%
1 Year
+72.7%
+72.7%

More News

Read More
BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
October 24, 2023
Via ACCESSWIRE
BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
October 17, 2023
Via ACCESSWIRE
BioStem Technologies: CMS Decision a “Win For Patients”
September 29, 2023
Via ACCESSWIRE
BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers
September 26, 2023
Via ACCESSWIRE
BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical
September 19, 2023
Via ACCESSWIRE
BioStem Technologies Engages PCG Advisory for Strategic Investor Relations
September 18, 2023
Via ACCESSWIRE
NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft
September 11, 2023
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond
January 30, 2023
Via Benzinga
2022 Year in Review: BioStem Technologies Looks Back At A Year of Growth And Expansion
January 13, 2023
Via Benzinga
BioStem Technologies Announces Partnership with Kill Cliff FC
December 14, 2022
From BioStem Technologies, Inc.
Via GlobeNewswire
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
November 15, 2022
From BioStem Technologies, Inc.
Via GlobeNewswire
BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
November 15, 2022
From BioStem Technologies, Inc.
Via GlobeNewswire
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
October 26, 2022
From BioStem Technologies, Inc.
Via GlobeNewswire
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
October 10, 2022
From BioStem Technologies, Inc.
Via GlobeNewswire
BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
September 22, 2022
Via Benzinga
EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY
May 16, 2022
Via Benzinga
Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness
April 22, 2021
Via Benzinga
Topics Cannabis
Exposures Cannabis

Frequently Asked Questions

Is Biostem Technologies Inc publicly traded?
Yes, Biostem Technologies Inc is publicly traded.
What exchange does Biostem Technologies Inc trade on?
Biostem Technologies Inc trades on the OTC Traded
What is the ticker symbol for Biostem Technologies Inc?
The ticker symbol for Biostem Technologies Inc is BSEM on the OTC Traded
What is the current price of Biostem Technologies Inc?
The current price of Biostem Technologies Inc is 15.20
When was Biostem Technologies Inc last traded?
The last trade of Biostem Technologies Inc was at 05/12/25 03:58 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap